Aim: Recently indoleamine 2,3-dioxygenase (IDO) has drawn considerable attention as a mechanism of immune regulation. Our study was to observe the role of IDO in immune tolerance of chronic hepatitis B (CHB), so as to provide a novel approach for reestablishment of active immunity.
Methods: Peripheral venous blood samples were taken from 50 CHB patients and HBV viral load, T lymphocyte subsets as well as the mRNA, protein and activity of IDO were detected. The correlations between HBV viral load, T lymphocyte subsets and IDO were statistically analyzed. Blood samples from 50 healthy people were tested as a control group.
Results: In CHB patients, the mRNA, protein and activity of IDO were all significantly more than those in control group (mRNA:[2.11 ± 0.615] × 103 vs. [0.143 ± 0.026] × 103; protein: 0.22 ± 0.06 vs. 0.02 ± 0.0017; activity: 26.07 ± 8.12 vs. 4.98 ± 1.65; P < 0.05) and IDO mRNA was positively correlated with HBV viral load (r = 0.502, P < 0.001) and alanine aminotransferase (ALT) (r = 0.65, P < 0.01). Furthermore, IDO mRNA, protein and activity were negatively correlated with CD4(+) T cells (r = −0.622, −0.682, −0.549 respectively, P < 0.05), CD8 (+) T cells (r = −0.487, −367, −294 respectively, P < 0.05) and the ratio of CD4/CD8 (r = −0.426, −0.533, −0.397 respectively, P < 0.05).
Conclusion: IDO closely correlates with HBV viral load and is responsible for immunotolerance against HBV. Suppression of IDO could be a novel approach to break tolerance in CHB.
If you can't find a tool you're looking for, please click the link at the top of the page to "Go to old article view". Alternatively, view our Knowledge Base articles for additional help. Your feedback is important to us, so please let us know if you have comments or ideas for improvement.